Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine
Clinical trial NCT04179474 · COMPLETED
Trial details
- NCT number
- NCT04179474
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2019-12-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.